ONYERO OSEMIHA: Open Payments
NPI 1326470824 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 23 payments from 6 companies in 2025. Trend: 2023 $408 · 2024 $550 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $194 |
| Veloxis Pharmaceuticals, Inc. | 3 | $91 |
| Alexion Pharmaceuticals, Inc. | 4 | $78 |
| NxStage Medical, Inc. | 2 | $39 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $20 |
Products named: FARXIGA, ENVARSUS, ULTOMIRIS, NXSTAGE SYSTEM ONE, CRYSVITA.
Industry payments across TX — which companies pay providers there.
